专利号:US-9315483-B2 优先权日:2007-09-13 标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof 发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT 权利人:CONCERT PHARMACEUTICALS INC 摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.
专利号:US-8063062-B2 优先权日:2006-12-20 标 题 :Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition 发明人:LANGE JOSEPHUS H M; KRUSE CORNELIS G; SHADID BELAL 权利人:LANGE JOSEPHUS H M; KRUSE CORNELIS G; SHADID BELAL; SOLVAY PHARM BV 摘要:Embodiments of this invention relate to compounds having a combination of cannabinoid-CB 1 antagonism and cholinesterase inhibition, to pharmaceutical compositions comprising these compounds, to methods for preparing these compounds, methods for preparing novel intermediates useful for the synthesis of these compounds, and methods for preparing compositions comprising these compounds. The invention also relates to methods of treating Alzheimer's disease, cognitive disorders, memory disorders, dementia, attention deficit disorder, traumatic brain injury, drug dependence, addiction or substance abuse by administering a pharmaceutical composition comprising these compounds to a patient in need thereof. A compound with a combination of cannabinoid-CB 1 antagonism and cholinesterase inhibition is a compound of formula (1) n nwherein the symbols have the meanings given in the specification.
专利号:WO-2009035652-A1 优先权日:2007-09-13 标 题 :Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
专利号:US-2014336387-A1 优先权日:2007-09-13 标题:Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
专利号:EP-2727915-A1 优先权日:2007-09-13 标题:Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
专利号:CA-2698808-A1 优先权日:2007-09-13 标题:Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
1: Braida D, Sala M. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. CNS Drug Rev. 2001 Winter;7(4):369-86. doi: 10.1111/j.1527-3458.2001.tb00205.x. 2: Sahoo AK, Dandapat J, Dash UC, Kanhar S. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease. J Ethnopharmacol. 2018 Apr 6;215:42-73. doi: 10.1016/j.jep.2017.12.015. Epub 2017 Dec 14. 52(4):700-8. doi: 10.1212/wnl.52.4.700. 53(5):389-95. doi: 10.1016/0024-3205(93)90642-g. 38(7):610-7. doi: 10.1002/j.1552-4604.1998.tb04467.x. 11(1):17-24. doi: 10.1159/000017208. 45(4):373-6. doi: 10.1007/BF00265958. 3(3):CD000207. doi: 10.1002/14651858.CD000207.pub2. 9: Braida D, Ottonello F, Sala M. Eptastigmine improves eight-arm radial maze performance in aged rats. Pharmacol Res. 2000 Oct;42(4):299-304. doi: 10.1006/phrs.2000.0706. 140(2):364-9. doi: 10.1006/taap.1996.0232.
合成参考文献
摘要:Journal of Medicinal Chemistry., 37(1996), 1994 参考文献:10.1007/bf02246647 摘要:Duka T, Ott H, Rohloff A, Voet B. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills. Psychopharmacology (Berl). 1996 Feb;123(4):361–73. doi: 10.1007/bf02246647. 参考文献:10.1007/bf02247383 摘要:Meziane H, Mathis C, Paul SM, Ungerer A. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology (Berl). 1996 Aug;126(4):323–30. doi: 10.1007/bf02247383. 参考文献:10.2165/00002018-199920060-00001 摘要:Zeitoun K, Carr BR. Is there an increased risk of stroke associated with oral contraceptives Drug Saf. 1999 Jun;20(6):467–73. doi: 10.2165/00002018-199920060-00001.